[HTML][HTML] Advances in the development of amorphous solid dispersions: The role of polymeric carriers

J Zhang, M Guo, M Luo, T Cai - Asian Journal of Pharmaceutical Sciences, 2023 - Elsevier
Amorphous solid dispersion (ASD) is one of the most effective approaches for delivering
poorly soluble drugs. In ASDs, polymeric materials serve as the carriers in which the drugs …

Amorphous solubility advantage: theoretical considerations, experimental methods, and contemporary relevance

K Ueda, DE Moseson, LS Taylor - Journal of Pharmaceutical Sciences, 2024 - Elsevier
Twenty-five years ago, Hancock and Parks asked a provocative question:“what is the true
solubility advantage for amorphous pharmaceuticals?” Difficulties in determining the …

New potential application of hydroxypropyl-β-cyclodextrin in solid self-nanoemulsifying drug delivery system and solid dispersion

JS Kim, YJ Choi, MR Woo, S Cheon, SH Ji, D Im… - Carbohydrate …, 2021 - Elsevier
The purpose of this study was to use hydroxypropyl-β-cyclodextrin (HP-β-CD) as a novel
carrier in solid SNEDDS and solid dispersions to enhance the solubility and oral …

Liquid–liquid phase separation drug aggregate: Merit for oral delivery of amorphous solid dispersions

P Zhao, W Han, Y Shu, M Li, Y Sun, X Sui, B Liu… - Journal of Controlled …, 2023 - Elsevier
As a promising strategy, amorphous solid dispersion has been extensively employed in
improving the oral bioavailability of insoluble drugs. Despite the numerous advantages, the …

Supersaturation and phase behavior during dissolution of amorphous solid dispersions

Y Kong, W Wang, C Wang, L Li, D Peng… - International Journal of …, 2023 - Elsevier
Amorphous solid dispersion (ASD) is a promising strategy to enhance solubility and
bioavailability of poorly water-soluble drugs. Due to higher free energy of ASD …

Partitioning of surfactant into drug-rich nanodroplets and its impact on drug thermodynamic activity and droplet size

K Ueda, LS Taylor - Journal of Controlled Release, 2021 - Elsevier
The excipients present in an amorphous solid dispersion (ASD) are essential functional
additives that ultimately influence the drug release performance and absorption. Herein, the …

Recent advances in enhancement of dissolution and supersaturation of poorly water-soluble drug in amorphous pharmaceutical solids: A review

Q Shi, F Li, S Yeh, SM Moinuddin, J **n, J Xu… - Aaps Pharmscitech, 2022 - Springer
Amorphization is one of the most effective pharmaceutical approaches to enhance the
dissolution and oral bioavailability of poorly water-soluble drugs. In recent years, amorphous …

Inhibition of Crystal Nucleation and Growth: A Review

Y Zhang, B Li, J Liu, D Han, S Rohani… - Crystal Growth & …, 2024 - ACS Publications
The formation of crystalline materials typically follows the nucleation and crystal growth
pathway, which enables scientists to engineer crystal properties, and the metastable status …

Polymer type impacts amorphous solubility and drug-rich phase colloidal stability: A mechanistic study using nuclear magnetic resonance spectroscopy

K Ueda, LS Taylor - Molecular Pharmaceutics, 2020 - ACS Publications
The polymer used in an amorphous solid dispersion (ASD) formulation plays a critical role in
dosage form performance. Herein, drug–polymer interactions in aqueous solution were …

The impact of water-soluble chitosan on the inhibition of crystal nucleation of alpha-mangostin from Supersaturated Solutions

A Budiman, N Nurfadilah, M Muchtaridi, S Sriwidodo… - Polymers, 2022 - mdpi.com
The use of an amorphous drugs system to generate supersaturated solutions is generally
developed to improve the solubility and dissolution of poorly soluble drugs. This is because …